Luyan
002788.SZLuyan Pharma Co.,Ltd. Price (002788.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
388,516,736
(0)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Luyan Pharma Co.,Ltd.Currency: CNY
| YEAR | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
2,948,581,496.00
+0% |
4,687,352,436.00
+59% |
5,519,752,155.00
+18% |
6,299,801,693.00
+14% |
6,625,719,875.00
+5% |
6,982,884,984.00
+5% |
8,338,232,823.00
+19% |
11,500,890,955.00
+38% |
15,008,876,118.00
+31% |
15,531,278,461.00
+3% |
17,545,397,267.00
+13% |
19,462,501,277.00
+11% |
19,845,534,614.00
+2% |
||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 2,714,514,839.00 | 4,327,218,905.00 | 5,048,625,428.00 | 5,763,358,885.00 | 6,097,548,028.00 | 6,452,679,504.00 | 7,688,428,959.00 | 10,600,987,081.00 | 13,839,484,235.00 | 14,297,099,245.00 | 16,174,212,472.00 | 17,947,344,516.00 | 18,339,050,593.00 | ||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
234,066,657.00
+0% |
360,133,531.00
+54% |
471,126,727.00
+31% |
536,442,808.00
+14% |
528,171,847.00
-2% |
530,205,480.00
+0% |
649,803,864.00
+23% |
899,903,874.00
+38% |
1,169,391,883.00
+30% |
1,234,179,216.00
+6% |
1,371,184,795.00
+11% |
1,515,156,761.00
+10% |
1,506,484,021.00
-1% |
||||||
| Gross Profit Ratio | (0.08%) | (0.08%) | (0.09%) | (0.09%) | (0.08%) | (0.08%) | (0.08%) | (0.08%) | (0.08%) | (0.08%) | (0.08%) | (0.08%) | (0.08%) | ||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 628,045.00 | 2,642,688.00 | 5,187,536.00 | 3,860,574.00 | 2,972,163.00 | 4,146,496.00 | 5,534,269.00 | ||||||
| General and Administrative | 59,678,083.00 | 18,288,259.00 | 26,351,521.00 | 25,303,444.00 | 22,093,121.00 | 25,535,305.00 | 29,478,391.00 | 39,639,581.00 | 42,336,078.00 | 36,045,289.00 | 43,122,341.00 | 47,328,469.00 | 307,878,250.00 | ||||||
| Selling, General & Admin... | 124,124,378.00 | 119,268,776.00 | 156,084,522.00 | 180,926,091.00 | 158,227,900.00 | 166,837,936.00 | 197,697,977.00 | 256,819,265.00 | 364,938,202.00 | 380,306,853.00 | 422,457,797.00 | 480,101,590.00 | 763,940,265.00 | ||||||
| Selling & Marketing Exp... | 64,446,294.00 | 100,980,517.00 | 129,733,001.00 | 155,622,646.00 | 136,134,778.00 | 141,302,630.00 | 168,219,585.00 | 217,179,684.00 | 322,602,124.00 | 344,261,563.00 | 379,335,455.00 | 432,773,121.00 | 441,712,879.00 | ||||||
| Depreciation and Amortiz... | 23,915,596.00 | 7,722,121.00 | 10,792,548.00 | 17,486,516.00 | 20,334,953.00 | 26,223,030.00 | 32,776,284.00 | 47,714,978.00 | 55,375,085.00 | 60,372,620.00 | 124,394,777.00 | 123,663,754.00 | 130,428,940.00 | ||||||
| Other Expenses | 641,720.00 | 1,941,064.00 | 1,760,800.00 | 5,736,292.00 | 3,505,122.00 | 3,433,643.00 | 1,847,649.00 | -1,173,240.11 | 266,325,760.00 | 262,532,779.00 | 307,512,766.00 | 285,690,577.00 | 268,453,011.00 | ||||||
| Total Operating Expenses | 128,775,251.00 | 192,949,899.00 | 257,321,402.00 | 302,392,431.00 | 283,360,172.00 | 299,860,245.00 | 368,075,337.00 | 505,517,521.00 | 636,451,500.00 | 646,700,207.00 | 732,942,726.00 | 769,938,664.00 | 1,037,927,545.00 | ||||||
| Cost and Exponses | 2,843,290,091.00 | 4,520,168,805.00 | 5,305,946,831.00 | 6,065,751,316.00 | 6,380,908,201.00 | 6,752,539,750.00 | 8,056,504,297.00 | 11,106,504,603.00 | 14,475,935,735.00 | 14,943,799,452.00 | 16,907,155,198.00 | 18,717,283,181.00 | 19,376,978,138.00 | ||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
85,521,222.00
+0% |
121,312,856.00
+42% |
145,521,981.00
+20% |
146,181,342.00
+0% |
152,226,943.00
+4% |
154,020,615.00
+1% |
198,647,141.00
+29% |
260,938,425.00
+31% |
547,013,564.00
+110% |
589,096,398.00
+8% |
645,087,376.00
+10% |
740,434,262.00
+15% |
468,556,476.00
-37% |
||||||
| Operating Income Ratio | (0.03%) | (0.03%) | (0.03%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.02%) | ||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | -0.53 | 39,023,745.00 | 1,531,560.00 | 2,307,833.00 | 400,552.00 | 1,944,515.00 | 2,299,917.00 | 1,528,727.00 | 1,575,560.00 | 11,660.00 | 5,181,258.00 | 3,858,412.00 | 5,142,019.00 | ||||||
| Interest Expenses | 16,084,090.00 | 0.00 | 59,009,348.00 | 76,315,187.00 | 78,141,850.00 | 60,849,159.00 | 75,805,255.00 | 118,899,844.00 | 149,712,610.00 | 163,863,896.00 | 184,060,292.00 | 219,103,960.00 | 228,018,771.00 | ||||||
| Total Other Income/Exp... | 386,065.00 | -41,456,076.00 | 1,752,349.00 | 5,703,780.00 | 3,481,757.00 | -65,064,306.00 | -67,560,343.00 | -1,173,240.00 | -202,937,796.00 | -217,935,086.00 | -229,872,065.00 | -274,423,850.00 | 865,247.00 | ||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 109,436,818.00 | 171,805,964.00 | 220,412,292.00 | 245,686,826.00 | 254,185,504.00 | 239,848,419.00 | 312,479,346.00 | 432,474,933.00 | 546,343,361.00 | 591,397,377.00 | 712,047,034.00 | 807,925,415.00 | 819,730,422.00 | ||||||
| EBITDA ratio | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | (0.04%) | ||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 85,907,287.00 | 123,240,997.00 | 147,274,330.00 | 151,885,122.00 | 155,708,700.00 | 157,425,595.00 | 200,494,791.00 | 259,765,185.00 | 344,075,768.00 | 372,120,212.00 | 415,215,311.00 | 466,010,412.00 | 469,421,723.00 | ||||||
| Income Before Tax Ratio | (0.03%) | (0.03%) | (0.03%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | ||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 22,028,599.00 | 31,864,067.00 | 38,158,080.00 | 40,912,839.00 | 40,502,911.00 | 40,653,088.00 | 55,488,717.00 | 75,184,197.00 | 86,566,158.00 | 104,311,313.00 | 110,603,920.00 | 115,036,059.00 | 104,927,350.00 | ||||||
| Net Income | |||||||||||||||||||
| Net Income | 63,624,640.00
+0% |
90,513,942.00
+42% |
108,283,121.00
+20% |
109,327,452.00
+1% |
113,479,743.00
+4% |
115,523,095.00
+2% |
130,578,913.00
+13% |
180,324,647.00
+38% |
255,888,916.00
+42% |
266,627,871.00
+4% |
305,870,612.00
+15% |
345,155,498.00
+13% |
363,530,313.00
+5% |
||||||
| Net Income Ratio | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | (0.02%) | ||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.24 | 0.34 | 0.41 | 0.42 | 0.43 | 0.35 | 0.37 | 0.51 | 0.73 | 0.69 | 0.79 | 0.89 | 0.94 | ||||||
| Diluted EPS | 0.24 | 0.34 | 0.41 | 0.42 | 0.43 | 0.35 | 0.37 | 0.51 | 0.73 | 0.69 | 0.79 | 0.89 | 0.94 | ||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 260,038,938.00 | 263,678,958.00 | 262,403,830.00 | 262,610,583.00 | 263,344,459.00 | 332,991,431.00 | 350,558,679.00 | 351,007,735.00 | 351,007,558.00 | 388,516,736.00 | 388,516,736.00 | 388,516,736.00 | 386,734,380.00 | ||||||
| Diluted Share Outstanding | 260,038,938.00 | 263,678,958.00 | 262,403,830.00 | 262,610,583.00 | 263,344,459.00 | 332,991,431.00 | 350,558,679.00 | 352,078,956.00 | 351,007,558.00 | 388,516,736.00 | 388,516,736.00 | 388,516,736.00 | 388,516,736.00 | ||||||